Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy

Publisher： Karger

E-ISSN： 1421-9832|215|4|295-300

ISSN： 1018-8665

Source： Dermatology, Vol.215, Iss.4, 2007-10, pp. : 295-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia

By  

Case Reports in Dermatology, Vol. 3, Iss. 1, 2011-03 ,pp. : 60-63

Karger

Access to resources Recommend Favorite

Autoimmune Bullous Skin Diseases Occurring under Anti-Tumor Necrosis Factor Therapy: Two Case Reports

By  

Dermatology, Vol. 221, Iss. 3, 2010-08 ,pp. : 201-205

Karger

Access to resources Recommend Favorite

Anti-Tumor Necrosis Factor Alpha-Induced Psoriasiform Eruptions: Three Further Cases and Current Overview

By  

Dermatology, Vol. 213, Iss. 3, 2006-10 ,pp. : 182-186

Karger

Access to resources Recommend Favorite

Anti-Tumour Necrosis Factor-Induced Visceral and Cutaneous Leishmaniasis: Case Report and Review of the Literature

By  

Dermatology, Vol. 230, Iss. 3, 2015-01 ,pp. : 204-207

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study

By  

Dermatology, Vol. 225, Iss. 4, 2012-12 ,pp. : 312-319

Karger

Access to resources Recommend Favorite